Eightify vs Exin Therapeutics: Revenue, Funding & Team Size Compared
Eightify generates $550K in revenue; Exin Therapeutics generates $550K. Eightify and Exin Therapeutics are close to the same size by revenue. The table below compares Eightify and Exin Therapeutics on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  EightifyThis company |  Exin Therapeutics |
|---|---|---|
| Revenue | $550K | $550K |
| Team size | 5 | 5 |
| Founded | 2022 | 2025 |
| HQ | San Francisco, United States | San Francisco, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Eightify at a glance
Eightify generates $550K in revenue with 5 employees, headquartered in San Francisco, United States.
- Revenue
- $550K
- Team size
- 5
- Founded
- 2022
AI-Powered Video Summaries
Exin Therapeutics at a glance
Exin Therapeutics generates $550K in revenue with 5 employees, headquartered in San Francisco, United States.
- Revenue
- $550K
- Team size
- 5
- Founded
- 2025
AI drug discovery platform for neurotherapeutics
Other Eightify alternatives
Eightify competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Eightify vs Exin Therapeutics: frequently asked questions
Is Eightify or Exin Therapeutics bigger?
Eightify is the bigger company by revenue, at $550K against $550K for Exin Therapeutics.
How much revenue does Eightify make?
Eightify generates $550K in annual revenue with a team of 5.
How much revenue does Exin Therapeutics make?
Exin Therapeutics generates $550K in annual revenue with a team of 5.